Danielle D. Jandial

Birth outcomes in teenage pregnancies.

W. Gilbert, N. Field, B. Danielsen, 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Birth outcomes in teenage pregnancies

W. Gilbert, N. Field, B. Danielsen, 2004 .

Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin

Chunli Wu, X. Zi, B. Hoang, 2017, Molecules.

Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.

S. Howell, K. Messer, Minya Pu, 2009, Gynecologic oncology.

Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum.

Jennifer S. Park, S. Howell, J. Kinsella, 2011, Small.

Molecular targeted approaches to cancer therapy and prevention using chalcones.

Yan-Bing Zhang, Christopher A. Blair, X. Zi, 2014, Current cancer drug targets.

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.

H. Iwata, D. Finkelstein, C. Barrios, 2019, The Lancet. Oncology.

Epidemiology of benign giant cell tumor of bone in the Chinese population

Steven S. Wong, A. Liede, R. Hernandez, 2018, Journal of bone oncology.

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

J. Blay, P. Rutkowski, S. Schuetze, 2019, The Lancet. Oncology.

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

B. Monk, R. Holcombe, X. Zi, 2012, Gynecologic oncology.

Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology

N. Raje, E. Terpos, Danielle D. Jandial, 2019, Dentistry journal.

Enhanced Delivery of Cisplatin to Intraperitoneal Ovarian Carcinomas Mediated by the Effects of Bortezomib on the Human Copper Transporter 1

Gregory I. Elliott, W. Wrasidlo, S. Howell, 2009, Clinical Cancer Research.

A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer

M. Chambers, S. Fedele, C. Politis, 2017, Supportive Care in Cancer.

The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.

B. Blair, S. Howell, R. Safaei, 2010, Biochemical pharmacology.